Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Mirum Pharmaceuticals (MIRM) Tax Provisions: 2019-2024

Historic Tax Provisions for Mirum Pharmaceuticals (MIRM) over the last 6 years, with Dec 2024 value amounting to $1.0 million.

  • Mirum Pharmaceuticals' Tax Provisions fell 175.50% to -$262,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $593,000, marking a year-over-year decrease of 67.61%. This contributed to the annual value of $1.0 million for FY2024, which is 3.94% up from last year.
  • Per Mirum Pharmaceuticals' latest filing, its Tax Provisions stood at $1.0 million for FY2024, which was up 3.94% from $991,000 recorded in FY2023.
  • Over the past 5 years, Mirum Pharmaceuticals' Tax Provisions peaked at $1.0 million during FY2024, and registered a low of -$6.4 million during FY2022.
  • Over the past 3 years, Mirum Pharmaceuticals' median Tax Provisions value was $991,000 (recorded in 2023), while the average stood at -$1.5 million.
  • In the last 5 years, Mirum Pharmaceuticals' Tax Provisions surged by 516.67% in 2021 and then tumbled by 17,413.51% in 2022.
  • Mirum Pharmaceuticals' Tax Provisions (Yearly) stood at $6,000 in 2020, then spiked by 516.67% to $37,000 in 2021, then crashed by 17,413.51% to -$6.4 million in 2022, then skyrocketed by 115.47% to $991,000 in 2023, then rose by 3.94% to $1.0 million in 2024.